Marker
|
n (%)
|
---|
Benguela
|
Zaire
|
---|
ASAQ
|
AL
|
AL
|
DP
|
---|
n = 7
|
n = 7
|
n = 1
|
n = 7
|
n = 7
|
n = 1
|
n = 1
|
n = 3
|
n = 12
|
n = 12
|
n = 8
|
n = 8
|
n = 14
|
n = 14
|
n = 1
|
n = 1
|
---|
Reinf day 0
|
Reinf day failure
|
ETF
|
Reinf day 0
|
Reinf day failure
|
Recr day 0
|
Recr day failure
|
ETF
|
Reinf day 0
|
Reinf day failure
|
Recr day 0
|
Recr day failure
|
Reinf day 0
|
Reinf day failure
|
Recr day 0
|
Recr day failure
|
---|
K13
|
Wildtype
|
7 (100)
|
7 (100)
|
1 (100)
|
7 (100)
|
7 (100)
|
1 (100)
|
1 (100)
|
3 (100)
|
12 (100)
|
12 (100)
|
8 (100)
|
8 (100)
|
14 (100)
|
14 (100)
|
1 (100)
|
1 (100)
|
cytB
|
Wildtype
|
7 (100)
|
7 (100)
|
1 (100)
|
7 (100)
|
7 (100)
|
1 (100)
|
1 (100)
|
3 (100)
|
12 (100)
|
12 (100)
|
8 (100)
|
8 (100)
|
14 (100)
|
14 (100)
|
1 (100)
|
1 (100)
|
pfmdr1
a
|
NYD
|
5 (71)
|
5 (71)
|
1 (100)
|
5 (71)
|
5 (71)
|
–
|
–
|
1 (33)
|
7 (58)
|
7 (58)
|
5 (62)
|
5 (62)
|
7 (50)
|
8 (57)
|
–
|
–
|
NFD
|
1 (14)
|
1 (14)
|
–
|
2 (29)
|
2 (29)
|
1 (100)
|
1 (100)
|
–
|
3 (25)
|
5 (42)
|
3 (38)
|
3 (38)
|
5 (36)
|
4 (29)
|
1 (100)
|
1 (100)
|
YFD
|
–
|
–
|
–
|
–
|
–
|
–
|
–
|
–
|
–
|
–
|
–
|
–
|
1 (7)
|
1 (7)
|
–
|
–
|
YYD
|
1 (14)
|
–
|
–
|
–
|
–
|
–
|
–
|
2 (67)
|
2 (17)
|
–
|
–
|
–
|
1 (7)
|
1 (7)
|
–
|
–
|
YYY
|
–
|
1 (14)
|
–
|
–
|
–
|
–
|
–
|
–
|
–
|
–
|
–
|
–
|
–
|
–
|
–
|
–
|
- In addition to the asynonymous mutations listed in the table, the following synonomous mutations were also observed: pfmdr1 G102G (2 instances), pfmdr1 T1069T (15), pfmdr1 S1137S (1), cytB A295A (1), K13 P553P (1), K13 T535T (2)
-
ETF early treatment failure, Reinf reinfection, Recr recrudescence, ASAQ artesunate–amodiaquine, AL artemether–lumefantrine, DP dihydroartemisinin–piperaquine
-
a
pfmdr1 haplotype classified according to animo acids at positions 86, 184, and 1246